© 2024 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Blog Post
Merck Announces Abandonment of CCR5 drug for Treatment Experienced Patients

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

2 Comments

Barry

Sangamo Biosciences is having extroadinary results with their trials CD4 CCR5. Matt Sharp can testify to that. Sangamo will be prenting art CROI, (4 presentaions). EXPECT some early trial results. Everyone should tune in for any webcasts. This is extroadinary.

January 14, 2011

michael duggan

Hi Paul, Do you have any idea what happened to Apricitabine? Has it been passed? Best, Michael.

January 22, 2010

Advertisement

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.